897P HORMONET: Phase II trial of tamoxifen for patients (pts) with estrogen/progesterone receptor (ER/PR)-positive neuroendocrine tumors (NET) von Riechelmann, R.S.P., Strosberg, J., Al-Toubah, T., Durant, L., Spina Donadio, M.D., Mello, C.A.L.D., De Jesus, V.H.F., Felismino, T.C., Taboada, R.G., De Brot Andrade, L., Barros, M.

Volltext

767P - Comparison of chemoradiotherapy (CRT) followed by consolidation with cisplatin and 5-fluorouracil (CF) versus definitive CRT with carboplatin and paclitaxel (CP) in esophage... von Cesca, M.G., Pandolfi, N.C., Barros, M., de Jesus, V.H.F., Silva, V.S., Camandaroba, M., Felismino, T.C., Rodrigues, N., Riechelmann, R.P.

Volltext

Comparison of chemoradiotherapy (CRT) followed by consolidation with cisplatin and 5-fluorouracil (CF) versus definitive CRT with carboplatin and paclitaxel (CP) in esophageal canc... von Cesca, M.G., Pandolfi, N.C., Barros, M., de Jesus, V.H.F., Silva, V.S., Camandaroba, M., Felismino, T.C., Rodrigues, N., Riechelmann, R.P.

Volltext

1395P - Opportunist and serious infections in patients with neuroendocrine tumours treated with everolimus: A multicenter study of real world patients von Mauro, C.D.C., de Jesus, V.H.F., Barros, M., Costa, F.P., Weschenfelder, R.F., D’Agustini, N., Angel, M., Luca, R., Nuñez, J.E., O’Connor, J.M., Riechelmann, R.P.

Volltext

Timing to achieve complete response (CR) after definitive chemoradiotherapy (ChRT) in patients with squamous cell carcinoma of the anal (SCCAC) with and without HIV infection: A mu... von Camandaroba, M.P.G., Iseas, S., Taboada, R.G., Oliveira, C.P., Mauro, C.D.C., Xerfan, M.P., Barros, M., de Jesus, V.H.F., Felismino, T.C., Mello, C.A., Riechelmann, R.P.

Volltext

Opportunist and serious infections in patients with neuroendocrine tumours treated with everolimus: A multicenter study of real world patients von Mauro, C.D.C., de Jesus, V.H.F., Barros, M., Costa, F.P., Weschenfelder, R.F., D’Agustini, N., Angel, M., Luca, R., Nuñez, J.E., O’Connor, J.M., Riechelmann, R.P.

Volltext

537P - Timing to achieve complete response (CR) after definitive chemoradiotherapy (ChRT) in patients with squamous cell carcinoma of the anal (SCCAC) with and without HIV infectio... von Camandaroba, M.P.G., Iseas, S., Taboada, R.G., Oliveira, C.P., Mauro, C.D.C., Xerfan, M.P., Barros, M., de Jesus, V.H.F., Felismino, T.C., Mello, C.A., Riechelmann, R.P.

Volltext

1404TiP - HORMONET: Study of tamoxifen in well differentiated neuroendocrine tumours and hormone receptor positive expression von Barros, M., Felismino, T.C., de Jesus, V.H.F., Mello, C.A., Silva, V.S., Camandaroba, M., Rodrigues, N., Donadio, M.D., Nobrega, E., Chinen, L., De Brot, L., Weschenfelder, R.F., Rego, J.F., Carvalheira, J.B., Riechelmann, R.P.

Volltext

BISQUIT: A randomized phase II study of the administration of prebiotics and probiotics during definitive treatment with chemotherapy-radiotherapy for patients with squamous cell c... von Riechelmann, R.P., Camandaroba, M., Mello, C.A., Silva, V.S., de Jesus, V.H.F., Barros, M., Rodrigues, N., Donadio, M.D., Cavichiolli, M., Lima, V.C.C., Dias-Neto, E., Nunes, D.N., Carraro, D., De Brot, L., Aguiar, S., Silva, M.L.G.

Volltext

660TiP - BISQUIT: A randomized phase II study of the administration of prebiotics and probiotics during definitive treatment with chemotherapy-radiotherapy for patients with squamo... von Riechelmann, R.P., Camandaroba, M., Mello, C.A., Silva, V.S., de Jesus, V.H.F., Barros, M., Rodrigues, N., Donadio, M.D., Cavichiolli, M., Lima, V.C.C., Dias-Neto, E., Nunes, D.N., Carraro, D., De Brot, L., Aguiar, S., Silva, M.L.G.

Volltext

HORMONET: Study of tamoxifen in well differentiated neuroendocrine tumours and hormone receptor positive expression von Barros, M., Felismino, T.C., de Jesus, V.H.F., Mello, C.A., Silva, V.S., Camandaroba, M., Rodrigues, N., Donadio, M.D., Nobrega, E., Chinen, L., De Brot, L., Weschenfelder, R.F., Rego, J.F., Carvalheira, J.B., Riechelmann, R.P.

Volltext